Toby Michael Maher

Citada per

	Totes	Des de 2020
Citacions	38927	27393
Índex h	92	78
Índex i10	290	262

7000

3500

1750

5250

2010201120122013201420152016201720182019202020212022202320242025136 188 246 404 708 1154 1382 1881 2114 2712 3740 5038 5049 5848 6636 997

Accés públic

Mostra-ho tot

223 articles

18 articles

disponibles

no disponibles

Es basa en els requisits de les agències que proporcionen el finançament

Coautors

Athol U WellsProfessor of Respiratory Medicine, Imperial College,Correu electrònic verificat a rbht.nhs.uk
Philip L MolyneauxImperial CollegeCorreu electrònic verificat a imperial.ac.uk
Vincent CottinUniversity of LyonCorreu electrònic verificat a chu-lyon.fr
Michael KreuterMainz Center for pulmonary diseases, University of Mainz and Marienhaus Klinikum Mainz, GermanyCorreu electrònic verificat a marienhaus.de
Andrew G NicholsonHonorary Professor of Respiratory Pathology, Imperial College, LondonCorreu electrònic verificat a rbht.nhs.uk
Richard Gisli JenkinsMargaret Turner Warwick Chair of Thoracic Medicine Imperial College LondonCorreu electrònic verificat a imperial.ac.uk
Martin KolbProfessor of Medicine, McMaster University HamiltonCorreu electrònic verificat a mcmaster.ca
Davin Hansel 0057StudentCorreu electrònic verificat a mhs.mdp.ac.id
Costabel, UlrichRuhrlandklinik, University Medicine Essen, 45239 Essen, GermanyCorreu electrònic verificat a rlk.uk-essen.de
Tamera CorteUniversity of SydneyCorreu electrònic verificat a sydney.edu.au
Felix ChuaRespiratory Physician, Royal Brompton HospitalCorreu electrònic verificat a rbht.nhs.uk
Anne-Marie RussellProfessor College of Medicine and Dentistry University of BirminghamCorreu electrònic verificat a bham.ac.uk
Moisés SelmanInstituto Nacional de Enfermedades RespiratoriasCorreu electrònic verificat a iner.gob.mx
Bruno Crestaniuniversité paris diderotCorreu electrònic verificat a bch.aphp.fr
Peter M GeorgeRoyal Brompton and Harefield NHS Foundation TrustCorreu electrònic verificat a rbht.nhs.uk
Imre NothCorreu electrònic verificat a hscmail.mcc.virginia.edu
Pauline LukeyDirector, drug discovery and developmentCorreu electrònic verificat a target2treatment.com
Sujal DesaiProfessor of Practice (Thoracic Imaging), National Heart & Lung Institute, Imperial College LondonCorreu electrònic verificat a rbht.nhs.uk
Shervin AssassiThe University of Texas Health Science Center at HoustonCorreu electrònic verificat a uth.tmc.edu
Adam J ByrneImperial College LondonCorreu electrònic verificat a imperial.ac.uk

Segueix

Toby Michael Maher

Keck Medicine of University of Southern California

Correu electrònic verificat a usc.edu - Pàgina d'inici

Pulmonology


Títol Ordena per cites Ordena per any Ordena per títol	Citada per Citada per	Any
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ... New England Journal of Medicine 370 (22), 2071-2082, 2014	4755	2014
Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, L Richeldi, CC Thomson, Y Inoue, T Johkoh, ... American journal of respiratory and critical care medicine 205 (9), e18-e47, 2022	1723	2022
Nintedanib for systemic sclerosis–associated interstitial lung disease O Distler, KB Highland, M Gahlemann, A Azuma, A Fischer, MD Mayes, ... New England Journal of Medicine 380 (26), 2518-2528, 2019	1513	2019
Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report HR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ... American journal of respiratory and critical care medicine 194 (3), 265-275, 2016	1373	2016
Interstitial lung disease in systemic sclerosis: a simple staging system NSL Goh, SR Desai, S Veeraraghavan, DM Hansell, SJ Copley, ... American journal of respiratory and critical care medicine 177 (11), 1248-1254, 2008	1339	2008
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis TE Fingerlin, E Murphy, W Zhang, AL Peljto, KK Brown, MP Steele, ... Nature genetics 45 (6), 613-620, 2013	862	2013
Pulmonary fibrosis secondary to COVID-19: a call to arms? P Spagnolo, E Balestro, S Aliberti, E Cocconcelli, D Biondini, ... The Lancet Respiratory Medicine 8 (8), 750-752, 2020	595	2020
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial TM Maher, TJ Corte, A Fischer, M Kreuter, DJ Lederer, M Molina-Molina, ... The lancet Respiratory medicine 8 (2), 147-157, 2020	592	2020
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis PL Molyneaux, MJ Cox, SAG Willis-Owen, P Mallia, KE Russell, ... American journal of respiratory and critical care medicine 190 (8), 906-913, 2014	552	2014
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised … AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ... The lancet Respiratory medicine 8 (5), 453-460, 2020	507	2020
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? TM Maher, AU Wells, GJ Laurent European Respiratory Journal 30 (5), 835-839, 2007	429	2007
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development P Spagnolo, JA Kropski, MG Jones, JS Lee, G Rossi, T Karampitsakos, ... Pharmacology & therapeutics 222, 107798, 2021	406	2021
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes TL Reddy, M Tominaga, DM Hansell, J von der Thusen, D Rassl, ... European Respiratory Journal 40 (2), 377-385, 2012	404	2012
Global incidence and prevalence of idiopathic pulmonary fibrosis TM Maher, E Bendstrup, L Dron, J Langley, G Smith, JM Khalid, H Patel, ... Respiratory research 22, 1-10, 2021	391	2021
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury CJ Scotton, MA Krupiczojc, M Königshoff, PF Mercer, YCG Lee, ... The Journal of clinical investigation 119 (9), 2550-2563, 2009	391	2009
Short‐term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis NS Goh, RK Hoyles, CP Denton, DM Hansell, EA Renzoni, TM Maher, ... Arthritis & rheumatology 69 (8), 1670-1678, 2017	350	2017
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study RG Jenkins, JK Simpson, G Saini, JH Bentley, AM Russell, R Braybrooke, ... The lancet Respiratory medicine 3 (6), 462-472, 2015	333	2015
Pulmonary macrophages: a new therapeutic pathway in fibrosing lung disease? AJ Byrne, TM Maher, CM Lloyd Trends in molecular medicine 22 (4), 303-316, 2016	324	2016
PD-1 up-regulation on CD4⁺ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production LJ Celada, JA Kropski, JD Herazo-Maya, W Luo, A Creecy, AT Abad, ... Science translational medicine 10 (460), eaar8356, 2018	310	2018
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study RJ Allen, J Porte, R Braybrooke, C Flores, TE Fingerlin, JM Oldham, ... The Lancet respiratory medicine 5 (11), 869-880, 2017	300	2017

En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.

Articles 1–20

Cites per any

Cites duplicades

Cites combinades

Addició de coautorsCoautors

Segueix

Citada per

Coautors